305 related articles for article (PubMed ID: 32297582)
1. Role of Flavonoids in Neurodegenerative Diseases: Limitations and Future Perspectives.
Maan G; Sikdar B; Kumar A; Shukla R; Mishra A
Curr Top Med Chem; 2020; 20(13):1169-1194. PubMed ID: 32297582
[TBL] [Abstract][Full Text] [Related]
2. Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol.
Rahul ; Siddique YH
CNS Neurol Disord Drug Targets; 2021; 20(4):327-342. PubMed ID: 33511932
[TBL] [Abstract][Full Text] [Related]
3. Flavonoids in Neurodegeneration: Limitations and Strategies to Cross CNS Barriers.
Andrade PB; Grosso C; Valentao P; Bernardo J
Curr Med Chem; 2016; 23(36):4151-4174. PubMed ID: 27516197
[TBL] [Abstract][Full Text] [Related]
4. Neurodegenerative diseases: From available treatments to prospective herbal therapy.
Solanki I; Parihar P; Parihar MS
Neurochem Int; 2016 May; 95():100-8. PubMed ID: 26550708
[TBL] [Abstract][Full Text] [Related]
5. Flavonoids in the Treatment of Alzheimer's and Other Neurodegenerative Diseases.
Airoldi C; La Ferla B; D Orazio G; Ciaramelli C; Palmioli A
Curr Med Chem; 2018; 25(27):3228-3246. PubMed ID: 29424298
[TBL] [Abstract][Full Text] [Related]
6. Role of Morin in Neurodegenerative Diseases: A Review.
Kataria R; Sobarzo-Sanchez E; Khatkar A
Curr Top Med Chem; 2018; 18(11):901-907. PubMed ID: 29992884
[TBL] [Abstract][Full Text] [Related]
7. A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases.
Zhao J; Zhu M; Kumar M; Ngo FY; Li Y; Lao L; Rong J
CNS Neurol Disord Drug Targets; 2019; 18(2):103-114. PubMed ID: 30394219
[TBL] [Abstract][Full Text] [Related]
8. Understanding the broad-spectrum neuroprotective action profile of green tea polyphenols in aging and neurodegenerative diseases.
Mandel SA; Amit T; Weinreb O; Youdim MB
J Alzheimers Dis; 2011; 25(2):187-208. PubMed ID: 21368374
[TBL] [Abstract][Full Text] [Related]
9. Polyphenols and Their Impact on the Prevention of Neurodegenerative Diseases and Development.
Grabska-Kobyłecka I; Szpakowski P; Król A; Książek-Winiarek D; Kobyłecki A; Głąbiński A; Nowak D
Nutrients; 2023 Aug; 15(15):. PubMed ID: 37571391
[TBL] [Abstract][Full Text] [Related]
10. Considerations for the Use of Polyphenols as Therapies in Neurodegenerative Diseases.
Renaud J; Martinoli MG
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30995776
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effects of flavonoids in neurodegenerative disorders.
Spagnuolo C; Moccia S; Russo GL
Eur J Med Chem; 2018 Jun; 153():105-115. PubMed ID: 28923363
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant Effect of Flavonoids Present in Euterpe oleracea Martius and Neurodegenerative Diseases: A Literature Review.
de Oliveira NKS; Almeida MRS; Pontes FMM; Barcelos MP; de Paula da Silva CHT; Rosa JMC; Cruz RAS; da Silva Hage-Melim LI
Cent Nerv Syst Agents Med Chem; 2019; 19(2):75-99. PubMed ID: 31057125
[TBL] [Abstract][Full Text] [Related]
13. Neurodegenerative Diseases: Might Citrus Flavonoids Play a Protective Role?
Cirmi S; Ferlazzo N; Lombardo GE; Ventura-Spagnolo E; Gangemi S; Calapai G; Navarra M
Molecules; 2016 Sep; 21(10):. PubMed ID: 27706034
[TBL] [Abstract][Full Text] [Related]
14. Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases.
Mandel S; Youdim MB
Free Radic Biol Med; 2004 Aug; 37(3):304-17. PubMed ID: 15223064
[TBL] [Abstract][Full Text] [Related]
15. Hesperidin as a Neuroprotective Agent: A Review of Animal and Clinical Evidence.
Hajialyani M; Hosein Farzaei M; Echeverría J; Nabavi SM; Uriarte E; Sobarzo-Sánchez E
Molecules; 2019 Feb; 24(3):. PubMed ID: 30759833
[TBL] [Abstract][Full Text] [Related]
16. An overview of the neuroprotective potential of rosmarinic acid and its association with nanotechnology-based delivery systems: A novel approach to treating neurodegenerative disorders.
Fachel FNS; Schuh RS; Veras KS; Bassani VL; Koester LS; Henriques AT; Braganhol E; Teixeira HF
Neurochem Int; 2019 Jan; 122():47-58. PubMed ID: 30439384
[TBL] [Abstract][Full Text] [Related]
17. Role of curcumin and its nanoformulations in neurotherapeutics: A comprehensive review.
Mandal M; Jaiswal P; Mishra A
J Biochem Mol Toxicol; 2020 Jun; 34(6):e22478. PubMed ID: 32124518
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective Effects of Fisetin in Alzheimer's and Parkinson's Diseases: From Chemistry to Medicine.
Nabavi SF; Braidy N; Habtemariam S; Sureda A; Manayi A; Nabavi SM
Curr Top Med Chem; 2016; 16(17):1910-5. PubMed ID: 26845554
[TBL] [Abstract][Full Text] [Related]
19. Regulation of neuroinflammation by herbal medicine and its implications for neurodegenerative diseases. A focus on traditional medicines and flavonoids.
Suk K
Neurosignals; 2005; 14(1-2):23-33. PubMed ID: 15956812
[TBL] [Abstract][Full Text] [Related]
20. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
Barchet TM; Amiji MM
Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
